Your browser doesn't support javascript.
loading
Protocol for the development and validation of a patient reported measure (PRM) of treatment burden in stroke.
Gallacher, Katie I; Taylor-Rowan, Martin; Eton, David T; McLeod, Hamish; Kidd, Lisa; Wood, Karen; Sardar, Aleema; Quinn, Terry J; Mair, Frances S.
Affiliation
  • Gallacher KI; General Practice and Primary Care, University of Glasgow, Glasgow, Scotland, G12 8TB, UK.
  • Taylor-Rowan M; General Practice and Primary Care, University of Glasgow, Glasgow, Scotland, G12 8TB, UK.
  • Eton DT; Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, USA.
  • McLeod H; Mental Health and Wellbeing, Gartnavel Royal Hospital, Glasgow, Scotland, G12 0XH, UK.
  • Kidd L; Department of Nursing and Community Health, Glasgow Caledonian University, Glasgow, Scotland, G40BA, UK.
  • Wood K; General Practice and Primary Care, University of Glasgow, Glasgow, Scotland, G12 8TB, UK.
  • Sardar A; School of Medicine, University of Glasgow, Glasgow, Scotland, UK.
  • Quinn TJ; Institute of Cardiovascular and Metabolic sciences, University of Glasgow, Glasgow, Scotland, UK.
  • Mair FS; General Practice and Primary Care, University of Glasgow, Glasgow, Scotland, G12 8TB, UK.
Health Open Res ; 5: 17, 2023.
Article in En | MEDLINE | ID: mdl-38708032
ABSTRACT

Background:

Treatment burden is the workload of healthcare for people with long-term conditions and the impact on wellbeing. A validated measure of treatment burden after stroke is needed. We aim to adapt a patient-reported measure (PRM) of treatment burden in multimorbidity, PETS (Patient Experience with Treatment and Self-Management version 2.0), to create a stroke-specific measure, PETS-stroke. We aim to examine content validity, construct validity, reliability and feasibility in a stroke survivor population.

Methods:

1) Adaptation of 60-item PETS to PETS-stroke using a taxonomy of treatment burden. 2) Content validity testing through cognitive interviews that will explore the importance, relevance and clarity of each item. 3) Evaluation of scale psychometric properties through analysis of data from stroke survivors recruited via postal survey (n=340). Factor structure will be tested with confirmatory factor analysis and Cronbach's alpha will be used to index internal consistency. Construct validity will be tested against The Stroke Southampton Self-Management Questionnaire; The Satisfaction with Stroke Care Measure; and The Shortened Stroke Impact Scale. We will explore known-groups validity by exploring the association between treatment burden, socioeconomic deprivation and multimorbidity. Test-retest reliability will be examined via re-administration after 2 weeks. Acceptability and feasibility of use will be explored via missing data rates and telephone interviews with 30 participants.

Conclusions:

We aim to create a validated PRM of treatment burden after stroke. PETS-stroke is designed for use as an outcome measure in clinical trials of stroke treatments and complex interventions to ascertain if treatments are workable for patients in the context of their everyday lives.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Health Open Res Year: 2023 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Health Open Res Year: 2023 Document type: Article Affiliation country: Reino Unido